Search results for "ADU"

showing 10 items of 20078 documents

Estudio del potencial patógeno de cepas de Saccharomyces cerevisiae aisladas de suplementos dietéticos y probióticos

2012

La levadura Saccharomyces cerevisiae es la especie más utilizada desde un punto de vista biotecnológico. Además, se emplea como suplemento dietético y como agente probiótico bajo el nombre de S. cerevisiae var. boulardii. Hasta ahora, su consumo se había considerado beneficioso por sus propiedades biofuncionales y su valor nutritivo intrínseco, y por otra parte, seguro, dado el carácter “GRAS” (de Generally Recognized As Safe) que se atribuye a esta especie de levadura; sin embargo, actualmente se considera a S. cerevisiae dentro del grupo de patógenos oportunistas emergentes de baja virulencia, capaz de causar infecciones principalmente en hospedadores inmunodeprimidos. Con el fin de conoc…

resistencia a estrés oxidativoUNESCO::CIENCIAS MÉDICASproductos dietéticosUNESCO::CIENCIAS DE LA VIDApatógeno emergenteSaccharomyces cerevisiae:CIENCIAS MÉDICAS [UNESCO]:CIENCIAS DE LA VIDA [UNESCO]factores de virulencia en levadura
researchProduct

The sense of smell also ages

2013

WOS:000324010400056 ; http://www.biofutur.com/; National audience

responseodor[ SDV.AEN ] Life Sciences [q-bio]/Food and Nutrition[SCCO.NEUR]Cognitive science/Neuroscienceadult[SCCO.NEUR] Cognitive science/Neuroscienceodorsinfantrats[SDV.AEN] Life Sciences [q-bio]/Food and Nutritionexperience[ SCCO.NEUR ] Cognitive science/Neuroscienceresponsesrat[SDV.AEN]Life Sciences [q-bio]/Food and NutritionComputingMilieux_MISCELLANEOUSattachment
researchProduct

Microvascular periodontal alterations: A possible relationship between periodontitis and rheumatoid arthritis.

2007

Abstract BACKGROUND: Microvascular involvements represent one of the first steps in many autoimmune diseases such as rheumatoid arthritis (RA). The aim of this study was to investigate the differences in periodontal microcirculation between healthy subjects and patients suffering from RA. METHODS: Thirty healthy subjects and 30 patients suffering from RA were examined. The patients who showed conditions known to compromise microcirculation, such as diabetes, hypertension, pharmacological treatments, were not included in the group of healthy patients. All the patients were non-smokers. Periodontal capillaroscopy was used to investigate the characteristics of microcirculation. Visibility, cou…

rheumatoid arthritisAdultMalePeriodontiumMicrocirculationMiddle AgedperiodontalCapillariesArthritis Rheumatoidperiodontal; rheumatoid arthritisCase-Control StudiesHumansFemalePeriodontitisAgedClinical hemorheology and microcirculation
researchProduct

Good clinical response, remission, and predictors of remission in rheumatoid arthritis patients treated with tumor necrosis factor-α blockers: The GI…

2007

OBJECTIVE: To assess the prevalence of good clinical response and remission in rheumatoid arthritis (RA) patients with longstanding disease treated with anti-tumor necrosis factor-alpha (TNF-alpha) drugs at outpatient clinics. METHODS: Retrospective national study of 14 academic tertiary referral rheumatology medical centers. RA patients with a Disease Activity Score (DAS28) > 3.2 were defined as having active disease and could start TNF-alpha blockers. All patients received one TNF-alpha blocker plus methotrexate (10-20 mg/wk). At the third month the patients were categorized as responders or nonresponders, based on improvement of at least 0.25 of the Health Assessment Questionnaire (HAQ).…

rheumatoid arthritisAdultMaleQuality Assurance Health Carepredictors of remissionTumor Necrosis Factor blockersAntibodies Monoclonal HumanizedSeverity of Illness IndexReceptors Tumor Necrosis FactorEtanerceptArthritis RheumatoidRheumatoid arthritis; Good clinical response; Tumor Necrosis Factor blockersPredictive Value of TestsHumansRheumatoid arthritispredictors of remission; rheumatoid arthritis; tumor necrosis factor-alpha blockersAgedRetrospective StudiesGood clinical responseTumor Necrosis Factor-alphatumor necrosis factor-alpha blockersRemission InductionAdalimumabAntibodies MonoclonalMiddle AgedPrognosisInfliximabLogistic ModelsMethotrexateTreatment Outcomedisability score; good clinical response; remission; rheumatoid arthritis; tumor necrosis factor-α blockersItalyAntirheumatic AgentsImmunoglobulin GFemale
researchProduct

Etanercept maintains the clinical benefit achieved by infliximab in patients with rheumatoid arthritis who discontinued infliximab because of side ef…

2007

Objective: To evaluate the efficacy of switching to etanercept treatment in patients with rheumatoid arthritis who already responded to infliximab, but presented side effects. Methods: Charts of 553 patients with rheumatoid arthritis were retrospectively reviewed to select patients who responded to the treatment with infliximab and switched to etanercept because of occurrence of adverse effects. Clinical data were gathered during 24 weeks of etanercept treatment and for the same period of infliximab treatment before infliximab was stopped. Disease Activity Score computed on 44 joints (DAS-44), erythrocyte sedimentation rate (ESR) 1st hour, Visual Analogue Scale (VAS) of pain, Health Assessm…

rheumatoid arthritisMaleConcise ReportArthritisGastroenterologyReceptors Tumor Necrosis FactorEtanerceptEtanerceptArthritis Rheumatoidimmune system diseasesImmunology and AllergyHealth Status Indicatorsskin and connective tissue diseasesmedicine.diagnostic_testbiologyAntibodies MonoclonalMiddle AgedC-Reactive ProteinTreatment OutcomeBiologic agents; etanercept; infliximab; infusion reactionRheumatoid arthritisErythrocyte sedimentation rateAntirheumatic AgentsFemalemedicine.drugmusculoskeletal diseasesAdultmedicine.medical_specialtyVisual analogue scaleImmunologyBlood Sedimentationinfusion reactionGeneral Biochemistry Genetics and Molecular BiologyRheumatologyInternal medicinemedicineHumansAdverse effectRetrospective StudiesChi-Square Distributionbusiness.industryTumor Necrosis Factor-alphaC-reactive proteinetanercept; infliximab; rheumatoid arthritismedicine.diseaseInfliximabInfliximabSurgeryBiologic agentsstomatognathic diseasesImmunoglobulin Gbiology.proteinbusinessinfliximabetanercept
researchProduct

Stima della fitness cardiorespiratoria (CRF) con un test "senza esercizio fisico" e associazione con indicatori convenzionali di rischio cardio-vasco…

2007

rischio CDC CRF GIOVANI ADULTI
researchProduct

Risk Perception of COVID-19, Religiosity, and Subjective Well-Being in Emerging Adults: The Mediating Role of Meaning-Making and Perceived Stress

2022

The pressured experienced due to COVID-19 for young people has become clearly visible in the domain of well-being. Although the psychological effects of the COVID-19 pandemic on emerging adults have been examined, little is known about the role played by risk perception and religiosity for their well-being. In addition, the mediating effects of meaning-making and perceived stress still need to be investigated. A total of 316 emerging adults (143 males and 173 females) participated in the present study. Using structural equation modeling (SEM) analysis, we showed that the relationship of risk perception of COVID-19 and religiosity with subjective well-being was largely mediated by meaning-m…

risk perception of COVID-19subjective well-beingperceived stressemerging adultsReligious studiesmeaning-makingreligiosityGeneral PsychologyJournal of Psychology and Theology
researchProduct

Senso, ritmo, multimodalità. Uno studio comparativo dei processi traduttivi nelle lingue dei segni (LIS e LSF)

2021

La presente tesi di dottorato analizza i processi traduttivi nelle lingue segnate, indagando la maniera di (re-)enunciare il senso in traduzione. La riflessione si costruisce come dialogo fra la linguistica delle lingue segnate e la traduttologia, a partire da presupposti teorici comuni a entrambe le discipline benché differentemente declinati, come il concetto di oralità. Lo studio, che intende definirsi come non assimilazionista (così come auspicato da C. Cuxac), tiene conto delle peculiarità proprie delle lingue segnate, fra cui le caratteristiche di multimodalità e multilinearità, e analizza le lingue dei segni sulla base del modèle sémiologique. Considerando la prospettiva dell’embodie…

ritmoprocessi traduttiviLSFmultilinearitàmultimodalitàLIScorpolingua dei segnilingua dei segni tattilesinestesiasensopoesiaSettore L-LIN/01 - Glottologia E Linguistica
researchProduct

5-6 gadu vecu bērnu radošās darbības sekmēšana rokdarbos

2020

Autores Natālijas Mūrnieces kvalifikācijas darba ‘’ 5-6 gadu vecu bērnu radošās darbības sekmēšana rokdarbos ‘’ mērķis ir izpētīt radošās darbības sekmēšanas iespējas rokdarbos pirmsskolā 5-6 gadus veciem bērniem. Pētījuma uzdevumi ir analizēt dažādu autoru literāri teorētiskās atziņas par radošumu, radošo darbību un tās attīstību pirmsskolas vecumā. Pētījuma teorētiskā daļa balstās uz K. Robinsona, R. Fišera, V. Hibneres, B. Frīdenbergas , D. Lieģenieces un citu autoru atziņām. Pētījuma empīriskā daļa balstās uz vecāku anketēšanas rezultātiem un praktisko pētījumu, kurā piedalās 12 bērni vecumā no 5-6 gadiem. Pētījuma sākumā tika veikta bērnu novērošana kā arī pēc izstrādātajiem bērnu snie…

rokdarbu nodarbībasradošuma attīstībaPirmsskolas pedagoģijaradošā darbība5-6 gadu veci bērniradošums
researchProduct

Fonemātiskās uztveres pilnveidošana 5 – 6 gadīgiem bērniem ar fonētiski fonemātiskiem traucējumiem rotaļās un spēlēs

2020

Darba nosaukums: ,,Fonemātiskās uztveres pilnveidošana 5 – 6 gadīgiem bērniem ar fonētiski fonemātiskiem traucējumiem rotaļās un spēlēs.’’ Darba autors: Ilva Bērziņa Darba zinātniskā vadītāja: Mg. paed. Ilze Vilka Darba saturs: 63 lappuses, 25 attēli, 1 tabula, 66 bibliogrāfiskie avoti, 10 pielikumi. Darba mērķis: teorētiski izzināt un praktiski pārbaudīt rotaļu un spēļu efektivitāti fonemātiskās uztveres pilnveidē 5 – 6 gadīgiem bērniem ar fonētiski fonemātiskiem traucējumiem. Pirmajā nodaļā darba autore ir pētījusi un analizējusi dažādu autoru teorētiskās atziņas par 5 – 6 gadus vecu bērnu raksturojumu veselumā, runas un valodas attīstību. Otrajā nodaļā tiek aplūkotas dažādu autoru atziņa…

rotaļas un spēles5 – 6 gadus veci bērniSkolas pedagoģijafonemātiskā uztverepilnveidošanafonētiski fonemātiskie traucējumi
researchProduct